Clariane SE (LTS:0OPS) Other Stockholders Equity: €2,096 Mil (As of Dec. 2025)


LTS:0OPS Clariane SE LTS:0OPS
61 GF Score
Price €4.23
GF Value €2.46
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Other Stockholders Equity?

Clariane SE LTS:0OPS +2.12% 61 Other Stockholders Equity is €2,096 Mil as of Dec. 2025. GuruFocus rates LTS:0OPS with a GF Score™ of 61/100 and a GF Value™ of €2.46 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Clariane SE's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €2,096 Mil.

Clariane SE's quarterly Other Stockholders Equity declined from Dec. 2024 (€2,174 Mil) to Jun. 2025 (€2,068 Mil) but then increased from Jun. 2025 (€2,068 Mil) to Dec. 2025 (€2,096 Mil).

Clariane SE's annual Other Stockholders Equity increased from Dec. 2023 (€1,843 Mil) to Dec. 2024 (€2,174 Mil) but then declined from Dec. 2024 (€2,174 Mil) to Dec. 2025 (€2,096 Mil).

Clariane SE Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Clariane SE's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariane SE Other Stockholders Equity Chart

Clariane SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,769.07 1,801.04 1,843.36 2,174.23 2,095.60

Clariane SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,843.36 2,189.67 2,174.23 2,067.63 2,095.60
LTS:0OPS
61GF Score
Clariane SE LTS:0OPS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clariane SE Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €2,096 Mil mean?
Clariane SE (LTS:0OPS) has a Other Stockholders Equity of €2,096 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Clariane SE and its competitors.
Is Clariane SE's Other Stockholders Equity too high?
Clariane SE's current Other Stockholders Equity is €2,096 Mil. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Other Stockholders Equity compare to HCA and THC?
Clariane SE's Other Stockholders Equity of €2,096 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Clariane SE and its competitors. Clariane SE's current Other Stockholders Equity is €2,096 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (LTS:0OPS) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.46, compared to a current price of €4.23 — trading 72.1% above its estimated fair value. The current Other Stockholders Equity is €2,096 Mil. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Clariane SE (LTS:0OPS), the current Other Stockholders Equity is €2,096 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (LTS:0OPS) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.23 is trading 72.1% above its estimated GF Value™ of €2.46. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for LTS:0OPS:

  • Other Stockholders Equity: €2,096 Mil
  • GF Value™: €2.46 vs. price of €4.23 (72.1% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the LTS:0OPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score

Get the complete analysis for LTS:0OPS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.23
Price
€2.46
GF Value